Teva's stock is a speculative buy with potential upside if biosimilars succeed, but risks remain high due to debt and ...

With the date of publication for a Critical Medicines Act fast approaching, the EU’s pharma industry is urging the Commission ...

We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to ...

The efforts over the past year by the team at Keros have positioned us to continue to advance our promising pipeline of novel therapeutics,” said Jasbir S. Seehra, Ph.D., Chair and Chief Executive ...

Takeda has returned to BridGene Biosciences for another small-molecule collaboration—this time focused on immunology as well ...

Takeda, a global biopharmaceutical company with a manufacturing site in Stanton Springs, unveiled its new Biomedical Waste ...

Recursion Pharmaceuticals, Inc.’s RXRX share price has dipped by 10.34%, which has investors questioning if this is right time to buy.

Patients with celiac disease have double the incidence rate of chronic liver disease compared with those without this ...

We recently compiled a list of the 12 Best Japanese Stocks To Buy in 2025. In this article, we are going to take a look at ...

Takeda Pharmaceutical Co. (TAK ... which is calculated by simply dividing a stock's price with the company's sales. This is a popular metric because sales are harder to manipulate on an income ...